149 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
24 Jan 24
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
8:01am
by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
11 Jan 24
Entry into a Material Definitive Agreement
4:07pm
and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
14 Nov 23
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:10pm
, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products
424B3
rc2ucdaennrmtsq15ni
5 Sep 23
Prospectus supplement
9:14pm
8-K
EX-99.1
85dyd
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
8-K
EX-99.2
3dp5b27j5v80 hfc
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
1inktm2sayina
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
loji5
23 Jun 23
Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
4:19pm
8-K
EX-99.1
ynx4rf
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
8-K
EX-99.1
xzunl9b
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm
8-K
EX-99.1
vkbr2t5l895c
20 Apr 23
Heron Therapeutics Announces Commercial Leadership Changes
9:10am
8-K
EX-99.1
kylrzeoinb0ud2xs42v3
3 Apr 23
Heron Therapeutics Announces New CEO and Board Chairman
9:10am